We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promethera Successfully Enrolls Twenty Patients in its Multicentric Phase I/II Trial

News   Nov 12, 2013

 
Promethera Successfully Enrolls Twenty Patients in its Multicentric Phase I/II Trial
 
 
 

RELATED ARTICLES

Drugs to Prevent Stroke and Dementia Show Promise in Early Trial

News

Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.

READ MORE

Targeted Therapy Proves Effective Against Aggressive Blood Cancer in Clinical Trial

News

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN).

READ MORE

Welding With Stem Cells to Make Surgical Glue

News

Scientists at the University of Bristol have invented a new technology that could lead to the development of a new generation of smart surgical glues and dressings for chronic wounds. The new method involves re-engineering the membranes of stem cells to effectively “weld” the cells together.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE